Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-07 Sale | 2024-03-11 6:27 pm | Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER | 12,464 | $90.69 | $1,130,360 | 153,177 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 9:24 pm | Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER | 6,640 | $45.69 | $303,354 | 125,641 (Direct) | View |
| 2022-11-03 Purchase | 2022-11-07 4:07 pm | Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER | 1,100 | $43.98 | $48,378 | 92,281 (Direct) | View |
| 2022-03-03 Sale | 2022-03-08 4:05 pm | Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF OPERATING OFFICER | 2,767 | $58.72 | $162,481 | 91,181 (Direct) | View |
| 2021-12-13 Sale | 2021-12-15 4:23 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $98.3 | $98,296 | 54,539 (Direct) | View |
| 2021-09-13 Sale | 2021-09-15 4:13 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $99.94 | $99,936 | 55,539 (Direct) | View |
| 2021-06-28 Sale | 2021-06-30 4:02 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $90.24 | $90,238 | 56,539 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 5:48 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $105.6 | $105,603 | 57,539 (Direct) | View |
| 2021-03-04 Sale | 2021-03-05 5:52 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,952 | $86.77 | $169,370 | 53,948 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 4:23 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 409 | $100.27 | $41,010 | 47,429 (Direct) | View |
| 2020-10-16 Sale | 2020-10-20 4:09 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 13,334 | $101.23 | $1,349,848 | 47,838 (Direct) | View |
| 2020-09-22 Sale | 2020-09-24 4:19 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 3,143 | $85.49 | $268,695 | 42,840 (Direct) | View |
| 2020-03-09 Sale | 2020-03-11 4:29 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 671 | $51.98 | $34,879 | 42,838 (Direct) | View |
| 2020-01-10 Sale | 2020-01-14 4:47 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 7,763 | $85.16 | $661,097 | 23,654 (Direct) | View |
| 2019-08-19 Sale | 2019-08-21 4:18 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 95 | $85 | $8,075 | 31,417 (Direct) | View |
| 2019-07-16 Sale | 2019-07-18 7:53 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,571 | $95.47 | $149,989 | 31,512 (Direct) | View |
| 2019-06-17 Sale | 2019-06-19 6:08 pm | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 11,952 | $96.46 | $1,152,870 | 51,417 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-06 4:18 pm | N/A 2034-03-01 | Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER | 120,000 | $0 | 245,641 (Direct) | View |
| 2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:07 pm | N/A 2033-03-01 | Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF EXECUTIVE OFFICER | 120,000 | $0 | 212,281 (Direct) | View |
| 2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 8:07 pm | N/A 2032-03-01 | Blueprint Medicines Corp | BPMC | Haviland Kate CHIEF OPERATING OFFICER | 120,000 | $0 | 173,948 (Direct) | View |
| 2021-12-13 Exercise | 2021-12-15 4:23 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $36.05 | 54,539 (Direct) | View |
| 2021-12-13 Exercise | 2021-12-15 4:23 pm | N/A 2027-02-16 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $0 | 54,539 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-15 4:13 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $36.05 | 55,539 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-15 4:13 pm | N/A 2027-02-16 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $0 | 55,539 (Direct) | View |
| 2021-06-28 Exercise | 2021-06-30 4:02 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $36.05 | 56,539 (Direct) | View |
| 2021-06-28 Exercise | 2021-06-30 4:02 pm | N/A 2027-02-16 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $0 | 56,539 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 5:10 pm | N/A 2031-06-08 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 5:48 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $36.05 | 57,539 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 5:48 pm | N/A 2027-02-16 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 1,000 | $0 | 57,539 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:30 pm | N/A 2031-03-01 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 39,187 | $0 | 82,025 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 4:23 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 409 | $36.05 | 47,429 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 4:23 pm | N/A 2027-02-16 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 409 | $0 | 47,429 (Direct) | View |
| 2020-10-16 Exercise | 2020-10-20 4:09 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 13,334 | $36.05 | 47,838 (Direct) | View |
| 2020-10-16 Exercise | 2020-10-20 4:09 pm | N/A 2027-02-16 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 13,334 | $0 | 47,838 (Direct) | View |
| 2020-09-22 Exercise | 2020-09-24 4:19 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 3,143 | $16.28 | 42,840 (Direct) | View |
| 2020-09-22 Exercise | 2020-09-24 4:19 pm | N/A 2026-02-01 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 3,143 | $0 | 42,840 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 4:15 pm | N/A 2030-06-10 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 9,285 | $0 | 9,285 (Direct) | View |
| 2020-03-01 Option Award | 2020-03-03 7:12 pm | N/A 2030-03-01 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 42,750 | $0 | 75,154 (Direct) | View |
| 2020-03-03 Exercise | 2020-03-03 7:12 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 4,644 | $16.28 | 75,154 (Direct) | View |
| 2020-03-03 Exercise | 2020-03-03 7:12 pm | N/A 2026-02-01 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 4,644 | $0 | 75,154 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:47 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 7,763 | $16.28 | 23,654 (Direct) | View |
| 2020-01-10 Exercise | 2020-01-14 4:47 pm | N/A 2026-02-01 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 7,763 | $0 | 23,654 (Direct) | View |
| 2019-08-19 Exercise | 2019-08-21 4:18 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 95 | $16.28 | 31,417 (Direct) | View |
| 2019-08-19 Exercise | 2019-08-21 4:18 pm | N/A 2026-02-01 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 95 | $0 | 31,417 (Direct) | View |
| 2019-07-16 Exercise | 2019-07-18 7:53 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 11,562 | $16.28 | 31,512 (Direct) | View |
| 2019-07-16 Exercise | 2019-07-18 7:53 pm | N/A 2026-02-01 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 11,562 | $0 | 31,512 (Direct) | View |
| 2019-07-18 Option Award | 2019-07-18 5:27 pm | N/A 2029-07-17 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 9,285 | $0 | 9,285 (Direct) | View |
Ownership | 2019-07-17 7:39 pm | N/A 2028-06-19 | Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director | 0 | $0 | 23,571 (Direct) | View |
| 2019-06-17 Exercise | 2019-06-19 6:08 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 5,666 | $36.05 | 51,417 (Direct) | View |
| 2019-06-17 Exercise | 2019-06-19 6:08 pm | N/A N/A | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 6,286 | $16.28 | 51,417 (Direct) | View |
| 2019-06-17 Exercise | 2019-06-19 6:08 pm | N/A 2026-02-01 | Blueprint Medicines Corp | BPMC | Haviland Kate Chief Operating Officer | 11,952 | $0 | 51,417 (Direct) | View |